Riken Vitamin Co., Ltd.
Tokyo Stock ExchangeTotal Valuation
Riken Vitamin Co., Ltd. carries a market capitalization of 90.92B, placing it among publicly traded companies globally. Its enterprise value stands at 70.28B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 90.92B |
| Enterprise Value | 70.28B |
Share Statistics
Riken Vitamin Co., Ltd. currently has 30.36M shares outstanding.
| Shares Outstanding | 30.36M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Riken Vitamin Co., Ltd. trades at a trailing price-to-earnings ratio of 15.40. The price-to-sales ratio is 1.67, and the price-to-book ratio stands at 1.13.
| PE Ratio | 15.40 |
| PS Ratio | 1.67 |
| PB Ratio | 1.13 |
| P/TBV Ratio | 1.02 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, Riken Vitamin Co., Ltd. trades at an EV/EBITDA multiple of 14.71 and an EV/FCF ratio of 1,720.28. The EV/Sales ratio of 1.50 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 14.71 provides insight into valuation relative to core operating earnings.
| EV / Sales | 1.50 |
| EV / EBITDA | 14.71 |
| EV / EBIT | 14.71 |
| EV / FCF | 1,720.28 |
Financial Position
Riken Vitamin Co., Ltd. maintains a current ratio of 2.36, meaning it holds 2.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 18.58, indicating elevated leverage, while an interest coverage ratio of 88.44 demonstrates strong ability to service its debt obligations.
| Current Ratio | 2.36 |
| Quick Ratio | 0.82 |
| Debt / Equity | 18.58 |
| Debt / EBITDA | 3.04 |
| Interest Coverage | 88.44 |
Financial Efficiency
Riken Vitamin Co., Ltd. posts a return on equity of 7.63 and a return on invested capital of 3.90.
| Return on Equity (ROE) | 7.63 |
| Return on Assets (ROA) | 4.44 |
| Return on Invested Capital (ROIC) | 3.90 |
| Return on Capital Employed (ROCE) | 6.37 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.66 |
Taxes
Over the trailing twelve months, Riken Vitamin Co., Ltd. has paid 1.64B in income taxes, reflecting an effective tax rate of 24.35.
| Income Tax | 1.64B |
| Effective Tax Rate | 24.35 |
Stock Price Statistics
Riken Vitamin Co., Ltd.'s stock has gained approximately 13.10821% over the past 52 weeks. The 50-day moving average sits at 2,874.54, while the 200-day moving average is 2,925.83.
| Beta (5Y) | N/A |
| 52-Week Price Change | 13.10821% |
| 50-Day Moving Average | 2,874.54 |
| 200-Day Moving Average | 2,925.83 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Riken Vitamin Co., Ltd. generated 46.87B in revenue and converted that into 5.09B in net income, yielding earnings per share of 167.69. EBITDA reached 4.78B, while operating income came in at 4.78B.
| Revenue | 46.87B |
| Gross Profit | 15.34B |
| Operating Income | 4.78B |
| Pretax Income | 6.73B |
| Net Income | 5.09B |
| EBITDA | 4.78B |
| EBIT | 4.78B |
| Earnings Per Share (EPS) | 167.69 |
Balance Sheet
Riken Vitamin Co., Ltd. holds 22.65B in cash and equivalents against 14.52B in total debt, resulting in a net debt position of -8.13B. Total book value stands at 69.54B, with working capital of 37.57B providing operational flexibility.
| Cash & Cash Equivalents | 22.65B |
| Total Debt | 14.52B |
| Net Debt | -8.13B |
| Equity (Book Value) | 69.54B |
| Book Value Per Share | 2,291.04 |
| Working Capital | 37.57B |
Margins
Riken Vitamin Co., Ltd. operates with a gross margin of 32.73, reflecting its pricing power and cost economics. The operating margin of 10.19 and net profit margin of 10.86 provide insight into operational efficiency.
| Gross Margin | 32.73 |
| Operating Margin | 10.19 |
| Pretax Margin | 14.35 |
| Profit Margin | 10.86 |
| EBITDA Margin | 10.19 |
Stock Splits
Riken Vitamin Co., Ltd.'s most recent stock split took place on March 30, 2020 with a 1:2 split ratio.
| Last Split Date | 3/30/2020 |
| Split Ratio | 1:2 |
Scores
Riken Vitamin Co., Ltd. posts an Altman Z-Score of 3.04, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 3.04 |